Page last updated: 2024-09-02

sr 140333 and sr141716

sr 140333 has been researched along with sr141716 in 2 studies

Compound Research Comparison

Studies
(sr 140333)
Trials
(sr 140333)
Recent Studies (post-2010)
(sr 140333)
Studies
(sr141716)
Trials
(sr141716)
Recent Studies (post-2010) (sr141716)
2360122,22960631

Protein Interaction Comparison

ProteinTaxonomysr 140333 (IC50)sr141716 (IC50)
Bile salt export pumpHomo sapiens (human)10
Cytochrome P450 3A4Homo sapiens (human)0.0069
Cannabinoid receptor 1Rattus norvegicus (Norway rat)0.0081
Cannabinoid receptor 1Homo sapiens (human)0.0219
Cytochrome P450 2C19Homo sapiens (human)0.0069
Cannabinoid receptor 2 Homo sapiens (human)2.4666
Cannabinoid receptor 1Mus musculus (house mouse)0.025
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.108
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)3.795

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borrelli, F; Capasso, F; Izzo, AA; Mascolo, N1
Bianchetti, A; Croci, T; Di Marzo, V; Di Palo, S; Ferla, G; Guagnini, F; Matias, I; Mukenge, S; Valenti, M1

Other Studies

2 other study(ies) available for sr 140333 and sr141716

ArticleYear
Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 359, Issue:1

    Topics: Animals; Atropine; Benzamides; Benzoxazines; Body Fluids; Cannabinoids; Defecation; Dose-Response Relationship, Drug; Gastrointestinal Motility; Hexamethonium Compounds; Intestines; Male; Mice; Morpholines; Muscarinic Agonists; Naphthalenes; Neurokinin-1 Receptor Antagonists; Piperidines; Pyrazoles; Quinuclidines; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Receptors, Muscarinic; Receptors, Neurokinin-2; Rimonabant

1999
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.
    Gut, 2006, Volume: 55, Issue:7

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Modulators; Case-Control Studies; Colon; Diverticulum; Endocannabinoids; Female; Glycerides; Humans; Imidazoles; Isoproterenol; Male; Middle Aged; Morpholines; Muscle Contraction; Muscle, Smooth; Naphthalenes; Neurokinin-1 Receptor Antagonists; Piperidines; Polyunsaturated Alkamides; Propanolamines; Pyrazoles; Quinuclidines; Rimonabant; Substance P; Tetrodotoxin

2006